Dr. Charalambos (Babis) Andreadis specializes in the treatment of lymphoma at the UCSF Helen Diller Family Comprehensive Cancer Center. His research focuses on individualized therapies targeting disease subtypes, and immune effector cell therapies for hematologic malignancies.

Andreadis earned his medical degree at Columbia University's Vagelos College of Physicians and Surgeons, and was elected to the Alpha Omega Alpha Honor Medical Society in 1998. He completed a residency at New York-Presbyterian Hospital and a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, where he joined the faculty in 2004. He also earned a master's degree in clinical epidemiology at the University of Pennsylvania, focusing on pharmacogenetics, the study of how genes impact an individual's response to medications. He presently leads the lymphoma program at UCSF and is the director of the Baszucki Lymphoma Therapeutic Initiative.